A study of the effects of rifabutin on isoniazid pharmacokinetics and metabolism in healthy volunteers.
The effect of repeated administration of rifabutin on the pharmacokinetics and metabolism of isoniazid was evaluated in 6 healthy volunteers. The subjects received on day 1 and 9 a single oral dose of 300 mg isoniazid and from day 2 to 8 a single daily oral dose of 300 mg rifabutin. Two out of 6 subjects were shown to be rapid acetylators. No significant modification of the plasma pharmacokinetic profiles of isoniazid and acetylisoniazid was found. Evidence exists in the present study for autoinduction of rifabutin metabolism; this is shown by the lower plasma concentrations obtained 24 h after the seventh dose as compared to the theoretical concentrations.
Breda
M
M
Farmitalia Carlo Erba, R&D-Erbamont Group, Milan, Italy.
Pianezzola
E
E
Strolin Benedetti
M
M
Efthymiopoulos
C
C
Carpentieri
M
M
Sassella
D
D
Rimoldi
R
R
D000107:Acetylation; D000328:Adult; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002851:Chromatography, High Pressure Liquid; D006207:Half-Life; D006801:Humans; D007538:Isoniazid / Q000031:analogs & derivatives / Q000493:pharmacokinetics*; D008297:Male; D010641:Phenotype; D017828:Rifabutin; D012294:Rifamycins / Q000494:pharmacology*; D013056:Spectrophotometry, Ultraviolet
D000900:Anti-Bacterial Agents; D012294:Rifamycins; C006377:(N)1-acetylisoniazid; D017828:Rifabutin; D007538:Isoniazid